You are here

CHS Directory

Displaying 626 - 650 of 1217

Please contact us to request changes to what portion of your contact information is displayed.

First Namesort ascending Last Name E-mail Telephone Institution Area of Expertise Address 1 Address 2 City State ZIP
Kimberley Hansen kjhansen@wfubmc.edu 336-713-5256 Wake Forest University School of Medicine renovascular disease (RVD) Head of the Section on Vascular and Endovascular Surgery Division of Surgical Sciences Winston-Salem North Carolina 27157
Kim Sutton-Tyrrell tyrrell@edc.pitt.edu (412) 624-1122 University of Pittsburgh Department of Epidemiology - Parran Hall 130 DeSoto Street Pittsburgh Pennsylvania 15261
Kim Chow heimanchow@ust.hk 852-23587345 Unknown abdominal obesity, active life, AD, Adipokines, adiponectin, adiposity, ADNI, Age, aging Alzheimers' diseas ApoE myocardial infarction (MI) diabetes frailty, Aging, Aging: Insulin Sensitivity, Alzheimer Disease, Alzheimer's dementia, Alzheimer's disease, Alzheimer’s disease, Alzheimer’s disease risk factors, Alzhiemer's disease, antidiabetic medications, apoE, apoE (genetic factors), APOE ε4, ApoE4, bioelectrical impedance, bioinformatics, biological aging, biomarker, biomarkers, Breast cancer, Caloric Intake, cancer, cancer progression, cardiometabolic, cardiometabolic disease, cardiometabolic risk, Cerebrovascular disease (CBD), cholesterol metabolites, dairy fatty acids, diabetes, Diabetes Mellitus, diabetes treatment, diet quality diet diversity diabetes cardiovascular disease, Diet; nutrition; epidemiology, dietary fat, dietary patterns, Dietary protein, gene expression, gene knockout, gene ontology, gene regulation, gene-based analysis, gene-diet interaction, gene-environment interaction, glucose, glucose intolerance, Glucose levels, glucose metabolism, GLUCOSE TOLERANCE, GLUCOSE TOLERANCE TEST, glycemic control, HMG CoA reductase inhibitors, HOMA-IR, hyperinsulinemia, HYPERINSULINISM, hyperlipidemia, hypertension, IGF-1, IGF-I, imflammation, inflammatory bowel disease, inflammatory marker, inflammatory markers, Inflammatory mediators, insulin, Insulin resistance, insulin-like growth factor 1 (IGF-1), insulin-like growth factors, insulinlike growth factors, IRS1, linoleic acid, Lipid fraction, lipid levels, lipid lowering agents, lipid markers, lipid metabolism, lipid peroxidation, lipids, lipis, lipohyalinosis, lipoprotein lipids, lipoprotein metabolism, lipoprotein subclasses, metabolic disorders, metabolic syndrome, metabolic traits, metabolism, metabolomics, neurodegeneration, neurodegenerative disease, next-generation sequencing, protein expression, Type 2 diabetes, Type 2 diabetes mellitus, women, women parity cardiovascular disease, Women's Health Room 6212, Division of Life Science Academic Concourse, HKUST, Hong Kong N/A 852
Kiang Liu kiangliu@northwestern.edu Northwestern University Medical School 680 No. Lake Shore Dr. Ste 1106 Chicago Illinois 60611-4402
Kevin D. Frick kfrick@jhsph.edu Johns Hopkins Bloomberg School of Public Health 624 N. Broadway, Rm. 606 Baltimore Maryland 21205-1901
Kevin Kolinich Kevin.Kolinich@uvm.edu University of Vermont Department of Pathology 208 South Park Drive, Ste. 2 Colchester Vermont 5446
Kevin McGeechan kevinm@health.usyd.edu.au The University of Sydney School of Public Health Room 322 - Edward Ford Building (A27) Sydney
Kerry Sheets sheet068@umn.edu University of Minnesota Aging N/A
Kerri L Wiggins kwiggins@u.washington.edu University of Washington BMI, dietary assessment, phenotype N/A
Kent Taylor kent.taylor@cshs.org Medical Genetics Institute, Cedars-Sinai Medical Center 8700 Beverly Blvd. Los Angeles California 90048
Kent Taylor ktaylor@lundquist.org 310-561-0612 Los Angeles Biomedical Research Institute coronary artery calcium, coronary artery disease, coronary atherosclerosis, coronary calcification, Cox Proportional Hazards, Cox regression, CVD events, data reduction, Databases, datasets, dbGaP, deep learning, diabetes, DNA methylation, DNA sequence, epigenomics, eQTL, ethnicity; diversity; prevention; cardiovascular;, exome chip, fasting glucose, fasting insulin, Fine-Gray method, Framingham risk scale, gene expression, Genetic analysis of cardiovascular-related traits, genetic factors (primary to CHS), genome wide association study, genotypes, glucose homeostasis, GWAS, hazard ratio, heart failure, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart failure; genetics, HOMA-B, HOMA-IR, impaired fasting glucose, incident CVD, incident diabetes, incident heart failure, Insulin resistance, Latent Class Analysis, latent variable models, left ventricular function, left ventricular hypertrophy, left ventricular mass, linear regression, logistic regression, Longitudinal Analysis, longitudinal change, LV, LV function, LV mass, LVH, Machine learning, MESA, Metabochip, metabolism, metabolomics, mitochondria, MRI, mtDNA, multi-ethnic, next-generation sequencing, NIDDM, non-insulin depend diabetes mellitus (NIDDM), obesity, omics, oral glucose tolerance test, pathogenic variants, pathway-based analysis, Polygenic Risk Scores, pre-diabetes, Principal components, Principal components adjustment, processing speed, proteomics, pulse pressure, pulse wave velocity, racial differences, Recursive partitioning, regularization, Sex-specific analysis, sparse partial least squares, Statistical methods, subclinical atherosclerosis, Subclinical vascular disease, Supervised learning, survival analysis, time-to-event regression, TOPMed, trajectories, trajectory, trans-ethnic., Type 2 diabetes, ventricular hypertrophy, ventricular size, ventricular volume, ventricular wall thickness, whole exome sequencing, whole gene sequencing (WGS) Institute for Translational Genomics and Population Sciences 1124 W. Carson Street Torrance California 90502
Kenshiro Fuse kfuse@hsph.harvard.edu (617) 495-1000 Harvard School of Public Health AF, CV risk, CVD, CVD epidemiology and prevention, CVD events, CVD incidence, CVD mortality, CVD risk factors, PAD, parity, stroke, Stroke incidence 677 Huntington Avenue Boston Massachusetts 02115
Kenneth Mukamal kmukamal@bidmc.harvard.edu 617-754-1401 Beth Israel Deaconess Medical Center diabetes Division of General Medicine Research Program 1309 Beacon Street Brookline Massachusetts 02446
Kenneth Rice kenrice@u.washington.edu University of Washington genome-wide association study N/A
Kelly Fujikawa Kelly.Fujikawa@ucdmc.ucdavis.edu UC Davis Aging N/A
Keattiyoat Wattanakit wattanakit@epi.umn.edu Epidemiology & Community Health Suite 300 1300 S. 2nd Street Minneapolis Minnesota 55455
Kazumasa Yamagishi kazumas.yamagishi.ge@u.tsukuba.ac.jp University of Minnesota Division of Epidemiology and Community Health School of Public Health, University of Minnesota Minneapolis Minnesota 55454
Kayode Kuku kayode.kuku@nih.gov NHLBI atherosclerosis, Atherosclerotic Cardiovascular Disease, biomarkers, cardiac biomarkers, cardiac imaging, congestive heart failure, congestive heart failure (CHF), coronary artery disease, coronary disease, coronary heart disease (CHD), coronary procedures, CVD epidemiology and prevention, heart failure, heart failure outcomes, Heart failure phenotype. HFpeF, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart failure; genetics, Imaging, percutaneous coronary intervention, Peripheral Artery Disease, peripheral vascular disease 9000 Rockville Pike Bldg. 10, Rm. 5N323 Bethesda Maryland 20892
Kaycee Sink kmsink@wfubmc.edu 336-713-8558 Wake Forest University Health Sciences J. Paul Sticht Center on Aging Medical Center Blvd. Winston-Salem North Carolina 27157
Katy Rahilly-Tierney CRAHILLY-TIERNEY@PARTNERS.ORG partners diabetes N/A
Kathryn A. Britton KBRITTON@PARTNERS.ORG Partners HealthCare diabetes N/A
Katherine Joyce kecjoyce@gmail.com BIDMC endocrine 330 Brookline Ave Boston Massachusetts 02215
Katherine Nishimura knishimu@fredhutch.org Fred Hutchinson Cancer Research Center epidemiology 1100 Fairview Avenue N Seattle Washington 98109
Katharina Weber katharina.weber@epi.uni-kiel.de Epidemiology & Community Health adiponectin, apoE, apolipoprotein, apolipoprotein E, apolipoproteins, association studies, C-Reactive Protein, C-reactive protein (CRP), cardiometabolic, cardiometabolic disease, cardiometabolic risk, cardiometabolic risk factors, cardiovascular disease, cardiovascular disease (CVD), cardiovascular disease epidemiology, cardiovascular risk factors, cholesterol, clinical epidemiology, Clustering, cognitive function, cognitive functioning, Cohort study, confounders, correlation, CRP, CV Epidemiology, CVD risk factors, Cytokines, diabetes, Diabetes Mellitus, diabetes risk prediction, diet, Diet; nutrition; epidemiology, dietary factors, dietary patterns, eating habits, Epidemiologic methods, epidemiological studies, epidemiology, follow-up study, food frequency, glucose homeostasis, glucose intolerance, Glucose levels, glucose metabolism, GLUCOSE TOLERANCE, GLUCOSE TOLERANCE TEST, glycemic control, Glycosylated Hemoglobin, HbA1c, HDL, HDL cholesterol, High-density lipoprotein (HDL), High-density lipoprotein cholesterol (HDL-C), HOMA-B, HOMA-IR, hyperglycemia, hyperlipidemia, IL-6, Impaired glucose tolerance, impaired glucose tolerance (IGT), inflammation and C-reactive protein (CRP), inflammatory marker, inflammatory markers, insulin, Insulin resistance, Insulin sensitivity, interaction, Interleukin-6, LDL, LDL cholesterol, LDL-C CHOLESTEROL, lifestyle factors, linear regression, lipid levels, Longitudinal Analysis, longitudinal observational data, longitudinal studies, longitudinal study, meta-analysis, nutrient intakes, nutrition, nutritional epidemiology, observational studies, oral glucose tolerance, oral glucose tolerance test, population-based, post-load glucose, pre-diabetes, prediabetes, Statistical methods, systematic reviews, triglycerides Niemannsweg 11 Kiel N/A 24105
Katey Webber katey.webber@gmail.com California Pacific Medical Center Research Institute Pooled Epidemiological studies N/A

Pages